Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2·4 mg for weight management: a randomised, controlled, phase 1b trial.
Safety, tolerability, pharmacokinetics and pharmacodynamics of the concomitant administration of multiple doses of cagrilintide with semaglutide 24 mg for weight management : a randomised, controlled phase 1b trial